Childress Capital Advisors, LLC Adaptive Biotechnologies Corp Transaction History
Childress Capital Advisors, LLC
- $352 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding ADPT
# of Institutions
228Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$220 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$107 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$85.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$78.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$69.1 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.05B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...